Evidence map›Paper›PMID 20500768›Full record

ArticleExperimental dermatology2010

PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation.

Renny J Starner, Lindy McClelland, Zalfa Abdel-Malek, Alex Fricke, Glynis Scott

Open access · bronzeAbstract readLetter
In one paragraph

Article in Experimental dermatology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Review
  3. [Exploration of Different Methods for Constructing Animal Models of Melasma in Plateau Regions].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2026
    Article
  4. Article
  5. Lipidome Complexity in Physiological and Pathological Skin Pigmentation.International journal of molecular sciences · 2025
    Review
  6. Article
  7. Vitiligo: From Pathogenesis to Treatment.Journal of clinical medicine · 2024
    Review
  8. Use of Tranexamic Acid in SARS-COV-2: Boon or Bane?Archives of Razi Institute · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Biology of melanocytes in mammals.Frontiers in cell and developmental biology · 2023
    Review
  13. Review
  14. Review
  15. Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Renny J Starner
Lindy McClelland
Zalfa Abdel-Malek
Alex Fricke
Glynis Scott
University of Rochester · USUniversity of Cincinnati · US

Funding

Signaling Pathways for UV-Induced Melanogenic ResponsesR01ES009110 · NIEHS · UNIVERSITY OF CINCINNATI · PI ABDEL-MALEK, ZALFA · 1998 to 2012
$3.8M
Role of Prostaglandins &Phospholipase A in melanocytesR01AR045427 · NIAMS · UNIVERSITY OF ROCHESTER · PI SCOTT, GLYNIS A · 1999 to 2009
$2.7M
NIAMS NIH HHS R01 AR045427NIAMS NIH HHS R01AR45427-04NIEHS NIH HHS 2R01ES009110NIEHS NIH HHS R01 ES009110
6 · The paper itself

Abstract

Prostaglandins activate signalling pathways involved in growth, differentiation and apoptosis. Prostaglandin E(2) (PGE(2)) is released by keratinocytes following ultraviolet irradiation (UVR) and stimulates the formation of dendrites in melanocytes. We show that multiple irradiations of human melanocytes with UVR-activated cPLA(2), the rate-limiting enzyme in eicosanoid synthesis and stimulated PGE(2) secretion. PGE(2) increased cAMP production, tyrosinase activity and proliferation in melanocytes. PGE(2) binds to four distinct G-protein coupled receptors (EP(1-4)). We show that PGE(2) stimulates EP(4) receptor signalling in melanocytes, resulting in cAMP production. Conversely, PGE(2) also stimulated the EP(3) receptor in melanocytes, resulting in lowered basal cAMP levels. These data suggest that relative levels or activity of these receptors controls effects of PGE(2) on cAMP in melanocytes. The data are the first to identify PGE(2) as an UVR-inducible autocrine factor for melanocytes. These data also show that PGE(2) activates EP(3) and EP(4) receptor signalling, resulting in opposing effects on cAMP production, a critical signalling pathway that regulates proliferation and melanogenesis in melanocytes.

Indexed as

Autocrine CommunicationCyclic AMPDinoprostoneEnzyme ActivationHumansInfant, NewbornIn Vitro TechniquesMaleMelanocytesMonophenol MonooxygenasePhospholipases A2, CytosolicReceptors, Prostaglandin EReceptors, Prostaglandin E, EP3 SubtypeReceptors, Prostaglandin E, EP4 SubtypeSignal TransductionUltraviolet RaysCyclic AMPDinoprostoneMonophenol MonooxygenasePhospholipases A2, CytosolicPTGER3 protein, humanPTGER4 protein, humanReceptors, Prostaglandin EReceptors, Prostaglandin E, EP3 SubtypeReceptors, Prostaglandin E, EP4 Subtype

Identifiers

PMID20500768
PMCPMC3649002
OpenAlexW1831538654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.